Stock Taper
SCREENER COMPARE ANY 2 STOCKS
AXSM
AXSOME THERAPEUTICS, INC.
NASDAQ
$199.02
▼ DOWN 3.51% (-7.25)

KEY STATISTICS

Market Cap$10.24 B
52w High$260.19
52w Low$112.90
Dividend Yield—
Frequency—
P/E-51.96
Volume441.18K
Shares Out.51.46M

COMPANY

LEADERSHIP

Herriot Tabuteau
CHIEF EXECUTIVE
Herriot Tabuteau

COMPENSATION 2026

Salary$835,000
Stock Awards$5,533,554
Incentive Plan Pay$876,750
All Other Comp.$204,951
Total$10,283,492

ABOUT

SECTOR
Healthcare
WENT PUBLIC
November 19, 2015
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
1,346

PRICE TARGET

Target High$380.00
Target Low$246.00
Target Median$275.00
Target Consensus$282.53

UPCOMING EARNINGS

DateNov 2, 2026
DayMonday
Rev. Est.$258.26M
NOV
2
MON

PRICE

$199.02 ▼ DOWN 3.51% (−$7.25)
$200$202$204$2069:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM199.02

About Axsome Therapeutics, Inc.

https://www.axsome.com ↗

Axsome Therapeutics, Inc. develops novel CNS disorder therapies, with products like AXS-05 and AXS-07 in clinical trials for depression, Alzheimer's agitation, migraine, narcolepsy, and fibromyalgia.

INDUSTRY

Biotechnology

A PRODUCT AXSOME THERAPEUTICS, INC. IS KNOWN FOR

Auvelity
Auvelity

Axsome Therapeutics' primary revenue-generating oral, extended-release tablet offers a novel, rapid-acting treatment for major depressive disorder in adults, representing a significant advancement in depression therapy.

COMPETITORS

COMPETITOR
ACAD COMPARE
BIIB COMPARE
JAZZ COMPARE
RLMD COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product$169.78M $194.69M ▲$189.4M ▼$216.35M ▲
Royalty$2.07M — $4.07M ▲$1.47M ▼
Milestone Revenue— — $500K $546K ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$169.18M $193.58M ▲$188.87M ▼$215.37M ▲
NonUS$1.21M $353K ▼$1.3M ▲$2.02M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
194
LISTED HERE
26
RANKED BY POSITION SIZE
VTS.AX
0.01% · 1.4M
FBT
2.67% · 387.2K
IBB
0.61% · 321.3K
SCHA
0.18% · 205.3K
FESM
0.42% · 135.2K
XCHA.DE
0.70% · 68.1K
PTH
3.56% · 48.7K
QMOM
1.72% · 36.2K
TMSL
0.24% · 34.7K
XPH
1.19% · 33.8K
PPH
0.62% · 30.8K
LYMD.DE
0.50% · 26.2K
JMOM
0.15% · 19.7K
LFSC
3.05% · 19.4K
JHMM
0.06% · 16.8K
BR
BRES
0.42% · 14.4K
FSCC
0.67% · 10.7K
BKMC
0.21% · 6.8K
BBP
0.99% · 5.7K
ROUS
0.08% · 2.9K
MNTL
2.33% · 2.3K
TILT
0.02% · 1.9K
BIB
0.36% · 1.8K
MEDI
0.71% · 1.5K
GUSA
0.01% · 1.3K
HELX
0.63% · 1.0K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
45.75%
HOLDERS
625
TOP 12 OF 625 · RANKED BY POSITION SIZE
Vanguard Group Inc
4.2M sh · $507.74M
Blackrock, Inc.
3.9M sh · $714.77M
Blackrock Inc.
3.3M sh · $265.65M
Invesco Ltd.
1.7M sh · $409.18M
Fmr LLC
1.6M sh · $264.85M
Vhcp Management Iii, LLC
1.5M sh · $160M
Price T Rowe Associates Inc /Md/
1.5M sh · $275.76M
Wellington Management Group Llp
1.3M sh · $162.08M
Geode Capital Management, LLC
1.2M sh · $196.6M
Deep Track Capital, LP
1.1M sh · $210.04M
Rtw Investments, LP
1.1M sh · $135.89M
Macquarie Group Ltd
1.1M sh · $131.72M

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

TRADES BY CONGRESS

HOUSE TRADES
Chris Jacobs
Chris Jacobs
Purchase
2022-06-16

INSIDER TRADES

★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER
TABUTEAU HERRIOT
Sale · 4.7K shares
2026-08-06
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER
TABUTEAU HERRIOT
Purchase · 45.0K shares
2026-08-05
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER
TABUTEAU HERRIOT
Purchase · 4.7K shares
2026-08-06
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER
TABUTEAU HERRIOT
Sale · 45.0K shares
2026-08-05

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 6
OUTPERFORM 4
OVERWEIGHT 2
EQUAL WEIGHT 1
13 GRADES IN THE LAST 12 MONTHS
Mizuho OUTPERFORM Wells Fargo OVERWEIGHT Guggenheim BUY Morgan Stanley EQUAL WEIGHT Needham BUY RBC Capital OUTPERFORM HC Wainwright & Co. BUY TD Cowen BUY

SECTORS PEERS

PEERPRICE
JAZZ$244.54COMPARE
ARWR$84.91COMPARE
CYTK$72.09COMPARE
PCVX$59.84COMPARE
ABVX$113.35COMPARE
RYTM$107.17COMPARE
CRSP$57.72COMPARE